Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.236 EUR -7.99%
Market Cap: 29.4m EUR

P/OCF
Price to OCF

-1.9
Current
-2.8
Median
19.8
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-1.9
=
Market Cap
29.4m EUR
/
Operating Cash Flow
-15.8m EUR
Market Cap P/OCF
FR
Gensight Biologics SA
PAR:SIGHT
29.4m EUR -1.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -229 667.2
US
Abbvie Inc
NYSE:ABBV
374.2B USD 19.9
US
Amgen Inc
NASDAQ:AMGN
169.1B USD 14.7
US
Gilead Sciences Inc
NASDAQ:GILD
131.9B USD 12.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
131.1B USD -266.1
US
Epizyme Inc
F:EPE
94.1B EUR -489.8
AU
CSL Ltd
ASX:CSL
123.3B AUD 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
72.6B USD 16.4
US
Seagen Inc
F:SGT
39.3B EUR -79.1
NL
argenx SE
XBRU:ARGX
34B EUR -142.1
 
FR
Gensight Biologics SA
PAR:SIGHT
Average P/OCF: 17.9
Negative Multiple: -1.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -229 667.2
US
Abbvie Inc
NYSE:ABBV
19.9
US
Amgen Inc
NASDAQ:AMGN
14.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -266.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -489.8
AU
CSL Ltd
ASX:CSL
26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -79.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -142.1

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A